Clement Clarke EU Scale Peak Flow Meter (Low Range)
This low range peak flow meter has a built-in one-way valve. It has an EU scale, which meets the new European standard EN13826.
The professional's guide to product selection
The professional's guide to product selection
This low range peak flow meter has a built-in one-way valve. It has an EU scale, which meets the new European standard EN13826.
The misuse of inhalers is common among people with asthma. Consequently, only small amounts of medication reach the patients’ lungs. The In-Check device helps to identify whether a patient is using their inhaler correctly by simulating the resistance of popular inhalers (MDIs and DPIs). This enables clinicians to train patients to use the optimal force to achieve optimal deposition of medication with a particular device.
Inspiratory flows in the range of 15 l/min to 120 l/ min can be measured. The In-Check device is accurate to +/- 10% or 10 l/min (whichever is greater).
The In-Check device is supplied with a sterilisable plastic mouthpiece and an adapter for a paediatric mouthpiece. A one-way disposable mouthpiece or a bacterial/viral filter can be used to minimise the risk of cross infection.
Stockists: Clement Clarke, Medisave.
Clement Clarke nebuliser kit with paediatric mouthpiece, nebuliser and tubing.
Stockists: GP Supplies.
Nebuliser kit with adult mouthpiece, nebuliser and tubing.
Stockists: Williams Medical Supplies, GP Supplies.
For prophylaxis of asthma by inhalation of aerosol
• Child 2–11 years: 100–200 mcg twice daily.
• Over 12 years: 200–400 mcg twice daily, increased if necessary up to 1 mg twice daily. Adjust according to response.
Antimuscarinic bronchodilator with short-acting selective beta2 agonist.
• Adult and child over 12 years for bronchospasm in chronic obstructive pulmonary disease: by inhalation of nebulised solution, 0.5/2.5 mg, 3–4 times daily.
Ipratropium with short-acting selective beta2 agonist.
For the treatment of bronchospasm in COPD
Adult: 0.5/2.5 mg 3–4 times a day.
Long-acting selective beta2 agonist with corticosteroid.
Combisal 25/125
• Over 12 years for prophylaxis of asthma: two inhalations twice daily.
Combisal 25/50
• Over 4 years for prophylaxis of asthma: two inhalations twice daily, but can be reduced to two inhalations once daily.
Combisal 25/250
• Over 12 years for prophylaxis of asthma: two inhalations twice daily.
Ipratropium with short-acting selective beta2 agonist.
For adult: 0.5/2.5 mg 3–4 times a day.